GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syschem (India) Ltd (BOM:531173) » Definitions » Deferred Policy Acquisition Costs

Syschem (India) (BOM:531173) Deferred Policy Acquisition Costs


View and export this data going back to 1995. Start your Free Trial

What is Syschem (India) Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Syschem (India) (BOM:531173) Business Description

Traded in Other Exchanges
N/A
Address
S.C.O. 825, 1st Floor, NAC Mani Majra, Chandigarh, PB, IND, 160101
Syschem (India) Ltd is a company that produces Active Pharmaceutical Ingredients and bulk drugs. It also undertakes contract manufacturing and custom synthesis business. In addition, the company is also involved in the purification of specialty solvents. The products offered by the company include Amoxycillin Tri-Hydrate, Ampicillin Tri-Hydrate, Cloxacillin Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Cephalexin, Cefixime, Cefadroxil, Distillation of Speciality Solvents - DMF, Acetonitrile, Ethyl Acetate, and THF.